BioCentury
ARTICLE | Clinical News

Orencia abatacept: Phase IIIb data

November 3, 2008 8:00 AM UTC

In a double-blind, Phase IIIb trial in 509 patients with early erosive RA, Orencia plus methotrexate met the primary endpoint of a significant improvement in DAS28 remission vs. methotrexate plus pla...